Shakrawal J, Sharma V, Goyal A, Kumar D, et al. Outcomes of transcutaneous retrobulbar Amphotericin B (TRAMB) as an adjuvant therapy for rhino-orbital-cerebral mucormycosis (ROCM) following COVID-19. Int Ophthalmol 2022 Nov 24. doi: 10.1007/s10792-022-02591.
PMID: 36427099